Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

558
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Development of the Heart01:27

Development of the Heart

3.2K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.2K
Cancer Therapies02:49

Cancer Therapies

10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

427
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
427
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies.

Cardio-oncology (London, England)·2026
Same author

Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia: A Prospective Study.

JACC. CardioOncology·2026
Same author

Ovarian carcinoid tumor with carcinoid heart syndrome: A case report and literature review.

Gynecologic oncology reports·2025
Same author

Spectrum of Perceptions Regarding Professional Climate: A National Survey of U.S. Cardiologists and Trainees.

JACC. Advances·2025
Same author

Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position Statement.

JAMA oncology·2025
Same author

The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitors.

Cardio-oncology (London, England)·2025

Related Experiment Video

Updated: Mar 6, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

How to Develop a Cardio-oncology Fellowship.

Michelle N Johnson1, Richard Steingart1, Joseph Carver2

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Heart Failure Clinics
|March 11, 2017
PubMed
Summary

Cardio-oncology expertise is crucial for managing cancer patients and survivors with cardiovascular disease. Enhanced training is needed due to cancer therapies causing cardiotoxicity and increasing cardiovascular risks.

Keywords:
Cancer therapeuticsCardio-oncologyCardiovascular diseaseFellowship

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

882
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Related Experiment Videos

Last Updated: Mar 6, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

882
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Area of Science:

  • Cardio-oncology
  • Oncology
  • Cardiovascular Medicine

Background:

  • Cancer patients and survivors face unique cardiovascular challenges.
  • Cancer therapies can cause cardiotoxicity and exacerbate existing cardiovascular conditions.
  • Many cancers are now chronic, increasing the long-term cardiovascular disease burden in survivors.

Purpose of the Study:

  • To highlight the need for specialized clinical expertise in cardio-oncology.
  • To underscore the importance of understanding cardiovascular complications from cancer treatments.
  • To advocate for enhanced cardio-oncology training.

Main Methods:

  • This study is a review of current knowledge and clinical practice in cardio-oncology.
  • It synthesizes information on cardiovascular complications of cancer therapies.
  • It discusses the management of cardiovascular comorbidities in cancer patients and survivors.

Main Results:

  • Cardio-oncology requires specific knowledge of cancer-related cardiovascular issues.
  • Cancer therapeutics frequently pose risks of cardiotoxicity.
  • The growing population of cancer survivors with chronic conditions increases cardiovascular disease prevalence.

Conclusions:

  • There is a significant and growing need for specialized cardio-oncology care.
  • Enhanced training is essential for physicians managing cardiovascular health in cancer patients and survivors.
  • Integrating oncology and cardiology expertise is vital for optimal patient outcomes.